The 11-year population-based study on bile duct injuries (BDIs) during laparoscopic cholecystectomies (LC) revealed an overall BDI incidence rate of 0.81%, with minor and major BDI rates of 0.68% and 0.13%, respectively. No significant decline in BDI incidence was observed over the study period, contradicting the hypothesis. Drainage and ERCP stent placement were the most […]
Category: HPB & Spleen
Effect of Hepatic Pedicle Clamping on Long-Term Survival following Hepatectomy for Hepatocellular Carcinoma
The study investigates the impact of hepatic pedicle clamping (HPC) on long-term survival in patients who underwent hepatectomy for hepatocellular carcinoma (HCC). The researchers analyzed data from a multicenter database and stratified patients based on whether they received intraoperative blood transfusion (IBT). While HPC did not significantly affect overall survival (OS) and recurrence-free survival (RFS) […]
Contrast-enhanced computed tomography can predict metastatic potential of small nonfunctioning pancreatic neuroendocrine tumors.
Tumor vascularity on contrast-enhanced computed tomography was studied for its predictive value in determining metastatic potential in small nonfunctioning pancreatic neuroendocrine tumors. The study included 77 patients who underwent pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors, with a focus on small tumors (≤2.0 cm). The results showed that the computed tomography a/e ratio was a useful […]
Augmented Reality Combined with Fluorescence Imaging Enhances Laparoscopic Segmentectomy for Hepatocellular Carcinoma
Augmented reality combined with indocyanine green fluorescence imaging guided laparoscopic segmentectomy for hepatocellular carcinoma significantly reduces intraoperative blood loss, decreases remnant liver ischemia, and improves disease-free survival rates at 1 and 3 years. This technology provides a standardized approach for liver parenchyma section and shows promising clinical application prospects. Journal Article by Wang D, Hu […]
Conditional survival rates and probabilities of death in patients with exocrine pancreatic cancer
Survival rates and probabilities of death in patients with exocrine pancreatic cancer (EPC) were investigated in a population-based study. The study found that the overall 5-year relative survival rate at diagnosis for pancreatic ductal adenocarcinoma (PDAC) was 8.5%. Among PDAC patients who survived for 2 years, the 3-year conditional survival rate was 50.1%, and among […]
Timing of EUS-Guided Drainage for Postoperative Pancreatic Fluid Collections
Early endoscopic ultrasound (EUS)-guided drainage can effectively manage postoperative pancreatic fluid collections (POPFCs) without increasing adverse events. Six retrospective studies involving 128 and 107 patients were analyzed, with the threshold for early and delayed drainage ranging from 14 to 30 days. Distal pancreatectomy was the main cause of POPFCs. The pooled odds ratio for adverse […]
Laparoscopic Resection of Liver Segment 4 with Fluorescence Staining: Feasibility and Efficacy
Researchers successfully performed a laparoscopic anatomic resection of liver segment 4 with middle hepatic vein involvement using indocyanine green fluorescence staining. The operation lasted 263 minutes with a 110-minute Pringle maneuver and 400g of estimated blood loss. The patient was discharged on postoperative day 5 without complications, and histopathology confirmed sigmoid carcinoma and R0 margin. […]
Comparison of Robotic-Assisted and Laparoscopic Liver Resection for Liver Malignancies
Robotic-assisted liver resection (RLR) and laparoscopic liver resection (LLR) have similar surgical and oncological outcomes for patients with liver malignancies. A systematic review and meta-analysis of five high-quality cohort studies, involving 986 patients, found no significant differences between RLR and LLR in terms of operation time, conversion to open surgery, complication rates, length of hospital […]
EPA for Metastasis Trial 2 (EMT2): Phase 3 Protocol for CRC Liver Metastasis Surgery
The EPA for Metastasis Trial 2 (EMT2) study protocol aims to address the need for safe and cost-effective adjunctive treatment for advanced colorectal cancer (CRC). The trial evaluates the effect of EPA on CRC outcomes in patients undergoing liver resection surgery for CRC liver metastasis. The primary endpoint is CRC progression-free survival, with key secondary […]
Long-term Survival Outcomes of Liver Resection for Metastatic Anal Squamous Cell Carcinoma
The study evaluated the outcomes of liver resection in patients with metastatic anal squamous cell carcinoma (SCC) to the liver. Among the 21 patients undergoing liver resection and/or ablation, 95% had undergone the Nigro protocol for the primary tumor, with 57% experiencing a complete response. The median overall survival was 32.2 months, and the 5-year […]